If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. |
|
|
Thread Tools | Display Modes |
#1
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
http://www.opednews.com/articles/gen...ts_head_to.htm
ADHD Experts Head To Washington - Is the FDA Up To The Task? Excerpts: Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the leading experts on attention deficit disorders at the FDA's Pediatric Advisory Committee's meeting on March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined have authored hundreds of books, papers and reports on attention deficit disorders.* And all five have one common goal; to put an end to the drugging for profit of the nation's most vulnerable citizens and pharma's most lucrative customer base - innocent children. "These children become for-profit receptacles for psychiatric drugs," he says, "which will, undoubtedly alter their bodies and brains." Studies have determined that ADHD drugs endanger the cardiovascular system and according to Dr Jackson, "the cardiovascular risks of stimulants are hardly new." "As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner documented the cell changes associated with heart muscle enlargement in a chronic consumer of Ritalin." "The connection between stimulants, cardiovascular disability, and death has long been documented in the medical literature," Dr Jackson notes, "but physicians and government regulators have refused to acknowledge the hazards associated with prescriptions." Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs are unnecessary and that their benefits outweigh their risks. "Whether by ignorance or design," Dr Jackson states, "the regulators remain oblivious to the evidence-based limitations of the prescription pad: at least 40% of all children fail to tolerate or respond to stimulant therapy; about twice as many respond at least as well to non-pharmacological interventions; and, as documented in the National Institute of Mental Health's most prestigious study to date (the MTA study), the long term outcomes for medicated children demonstrate diminishing returns over time, persistent suppression of growth (about 1 cm per year), and artificial behavioral improvements which dissipate when treatment is withdrawn." "Not surprisingly," she says, "the world community observes the United States with alarm for the unjustified chemical exploitation of those who are different, but not diseased." "It is hard to imagine a more serious warning flag than growth inhibition," he says, "since it affects the overall growth of the body and all its organs, including the brain." Its a well documented fact that the pharmaceutical industry funnels money to front groups, which in turn fund marketing campaigns and come out to do battle at times like this when drug company profits are threatened and scrutinized. On February 15, 2006, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed front group responsible for pushing ADHD drugs issued a press release criticizing the FDA Advisory Committee's recommendation last month to add black box warnings to the labels of stimulant drugs. The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and charged the organization with being a vehicle for marketing a controlled substance to the public in violation of the international statute known as the Controlled Substances Act of 1971. Ritalin is classified as a Schedule II medication. In order for a product to be classified as a Schedule II drug under the Federal Controlled Substances Act, it must meet three criteria: one, it has to have a high potential for abuse; two, it has to have a currently accepted medical use in treatment in the US; and three, it has to show that abuse may lead to severe psychological or physical dependence. It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin removed from the Schedule II class and moved into a less controlled group to make the drug easier to buy. DEA told Congress that police were reporting that Ritalin was being stolen, sold and traded on playgrounds, as well as snorted, injected, and cut much like any other amphetamine. Although the DEA presented a thorough report, nothing was done to slow the sale of Ritalin to children. And nothing changed as far as CHADD's employment status as a major pusher for Pharma either. For the fiscal year 2002-2003, the group's financial statements showed it received more than $670,000 from various drug companies. In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties between CHADD and the drug companies in an interview with Dr William Pelham, director of the Center for Children and Families at State University of New York at Buffalo, a leading ADHD researcher for 30 years, and a former advisory board member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta. Over his career, Dr Pelham has written over 250 research papers on ADHD, and in 2002, he even received a lifetime achievement award from CHADD. However, he has few good words to say about CHADD, regulatory officials, medical professionals, or anybody else involved in selling ADHD drugs to children. "In recent years," Dr Pelham told Alternet, "I have come to believe that the individuals who advocate most strongly in favor of medication - both those from the professional community, including the National Institutes of Mental Health, and those from advocacy groups, including CHADD - have major and undisclosed conflicts of interest with the pharmaceutical companies that deal with ADHD products." "I believe that parents of ADHD children and the public at large should be made aware of this situation," he told Ms Hearn. Representatives of CHADD showed up at the FDA hearings last month and the group will no doubt be out in full force this month ready to go head to head against pharma's number one enemy - the advocacy groups opposed to the mass drugging of children for profit. |
#2
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
Jan Drew wrote:
http://www.opednews.com/articles/gen...ts_head_to.htm ADHD Experts Head To Washington - Is the FDA Up To The Task? Excerpts: Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the leading experts on attention deficit disorders at the FDA's Pediatric Advisory Committee's meeting on March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined have authored hundreds of books, papers and reports on attention deficit disorders.* BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study in decades. Breggin's colleague quit that group because he could not stand Breggin's lies. Breggin has been discredited many times in court, when he was allowed to testify. He has not been allowed to testify many times. I previously documented this. Baughman is one of the promotors of the 5 now defunct and dismissed Ritalin lawsuits. He has never published any research regarding AD/HD. Ravenel has never published a research study on AD/HD. Does have some on spanking. Jackson has no published research papers on AD/HD. Stein has no published papers on AD/HD/. Searched PubMed using search string of Last Name, First Initial, AD/HD. BIG Yawn. And all five have one common goal; to put an end to the drugging for profit of the nation's most vulnerable citizens and pharma's most lucrative customer base - innocent children. Yes, Ms. Dingle does have a decidedly anti-medication bias. "These children become for-profit receptacles for psychiatric drugs," he says, "which will, undoubtedly alter their bodies and brains." Studies have determined that ADHD drugs endanger the cardiovascular system and according to Dr Jackson, "the cardiovascular risks of stimulants are hardly new." "As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner documented the cell changes associated with heart muscle enlargement in a chronic consumer of Ritalin." "The connection between stimulants, cardiovascular disability, and death has long been documented in the medical literature," Dr Jackson notes, "but physicians and government regulators have refused to acknowledge the hazards associated with prescriptions." Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs are unnecessary and that their benefits outweigh their risks. "Whether by ignorance or design," Dr Jackson states, "the regulators remain oblivious to the evidence-based limitations of the prescription pad: at least 40% of all children fail to tolerate or respond to stimulant therapy; about twice as many respond at least as well to non-pharmacological interventions; and, as documented in the National Institute of Mental Health's most prestigious study to date (the MTA study), the long term outcomes for medicated children demonstrate diminishing returns over time, persistent suppression of growth (about 1 cm per year), and artificial behavioral improvements which dissipate when treatment is withdrawn." "Not surprisingly," she says, "the world community observes the United States with alarm for the unjustified chemical exploitation of those who are different, but not diseased." "It is hard to imagine a more serious warning flag than growth inhibition," he says, "since it affects the overall growth of the body and all its organs, including the brain." Its a well documented fact that the pharmaceutical industry funnels money to front groups, which in turn fund marketing campaigns and come out to do battle at times like this when drug company profits are threatened and scrutinized. On February 15, 2006, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed front group responsible for pushing ADHD drugs issued a press release criticizing the FDA Advisory Committee's recommendation last month to add black box warnings to the labels of stimulant drugs. The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and charged the organization with being a vehicle for marketing a controlled substance to the public in violation of the international statute known as the Controlled Substances Act of 1971. Ritalin is classified as a Schedule II medication. In order for a product to be classified as a Schedule II drug under the Federal Controlled Substances Act, it must meet three criteria: one, it has to have a high potential for abuse; two, it has to have a currently accepted medical use in treatment in the US; and three, it has to show that abuse may lead to severe psychological or physical dependence. It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin removed from the Schedule II class and moved into a less controlled group to make the drug easier to buy. DEA told Congress that police were reporting that Ritalin was being stolen, sold and traded on playgrounds, as well as snorted, injected, and cut much like any other amphetamine. Although the DEA presented a thorough report, nothing was done to slow the sale of Ritalin to children. And nothing changed as far as CHADD's employment status as a major pusher for Pharma either. For the fiscal year 2002-2003, the group's financial statements showed it received more than $670,000 from various drug companies. In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties between CHADD and the drug companies in an interview with Dr William Pelham, director of the Center for Children and Families at State University of New York at Buffalo, a leading ADHD researcher for 30 years, and a former advisory board member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta. Over his career, Dr Pelham has written over 250 research papers on ADHD, and in 2002, he even received a lifetime achievement award from CHADD. However, he has few good words to say about CHADD, regulatory officials, medical professionals, or anybody else involved in selling ADHD drugs to children. "In recent years," Dr Pelham told Alternet, "I have come to believe that the individuals who advocate most strongly in favor of medication - both those from the professional community, including the National Institutes of Mental Health, and those from advocacy groups, including CHADD - have major and undisclosed conflicts of interest with the pharmaceutical companies that deal with ADHD products." "I believe that parents of ADHD children and the public at large should be made aware of this situation," he told Ms Hearn. Representatives of CHADD showed up at the FDA hearings last month and the group will no doubt be out in full force this month ready to go head to head against pharma's number one enemy - the advocacy groups opposed to the mass drugging of children for profit. |
#3
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
Twittering One wrote:
You know, as I have always said, ask the kid. If the kid hates the meds, something is wrong. If the kid feels better on the meds, feels better about his/her abilities, something is right. Agreed. Input from the patient, child or adult, is always important. I went for 24 years before I ever took a an ADD-like med (diet pill) and felt GOOD about my abilities. And then I went another 18 years without any medication options. If I had been offered a choice, I would have taken the meds. But that was another decade. |
#4
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
"Mark Probert" [please excuse Mark Probert hissy fits] Jan Drew wrote: http://www.opednews.com/articles/gen...ts_head_to.htm ADHD Experts Head To Washington - Is the FDA Up To The Task? Excerpts: Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the leading experts on attention deficit disorders at the FDA's Pediatric Advisory Committee's meeting on March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined have authored hundreds of books, papers and reports on attention deficit disorders.* BWHAHAHAHAHAHA! [snip] And all five have one common goal; to put an end to the drugging for profit of the nation's most vulnerable citizens and pharma's most lucrative customer base - innocent children. "These children become for-profit receptacles for psychiatric drugs," he says, "which will, undoubtedly alter their bodies and brains." Studies have determined that ADHD drugs endanger the cardiovascular system and according to Dr Jackson, "the cardiovascular risks of stimulants are hardly new." "As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner documented the cell changes associated with heart muscle enlargement in a chronic consumer of Ritalin." "The connection between stimulants, cardiovascular disability, and death has long been documented in the medical literature," Dr Jackson notes, "but physicians and government regulators have refused to acknowledge the hazards associated with prescriptions." Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs are unnecessary and that their benefits outweigh their risks. "Whether by ignorance or design," Dr Jackson states, "the regulators remain oblivious to the evidence-based limitations of the prescription pad: at least 40% of all children fail to tolerate or respond to stimulant therapy; about twice as many respond at least as well to non-pharmacological interventions; and, as documented in the National Institute of Mental Health's most prestigious study to date (the MTA study), the long term outcomes for medicated children demonstrate diminishing returns over time, persistent suppression of growth (about 1 cm per year), and artificial behavioral improvements which dissipate when treatment is withdrawn." "Not surprisingly," she says, "the world community observes the United States with alarm for the unjustified chemical exploitation of those who are different, but not diseased." "It is hard to imagine a more serious warning flag than growth inhibition," he says, "since it affects the overall growth of the body and all its organs, including the brain." Its a well documented fact that the pharmaceutical industry funnels money to front groups, which in turn fund marketing campaigns and come out to do battle at times like this when drug company profits are threatened and scrutinized. On February 15, 2006, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed front group responsible for pushing ADHD drugs issued a press release criticizing the FDA Advisory Committee's recommendation last month to add black box warnings to the labels of stimulant drugs. The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and charged the organization with being a vehicle for marketing a controlled substance to the public in violation of the international statute known as the Controlled Substances Act of 1971. Ritalin is classified as a Schedule II medication. In order for a product to be classified as a Schedule II drug under the Federal Controlled Substances Act, it must meet three criteria: one, it has to have a high potential for abuse; two, it has to have a currently accepted medical use in treatment in the US; and three, it has to show that abuse may lead to severe psychological or physical dependence. It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin removed from the Schedule II class and moved into a less controlled group to make the drug easier to buy. DEA told Congress that police were reporting that Ritalin was being stolen, sold and traded on playgrounds, as well as snorted, injected, and cut much like any other amphetamine. Although the DEA presented a thorough report, nothing was done to slow the sale of Ritalin to children. And nothing changed as far as CHADD's employment status as a major pusher for Pharma either. For the fiscal year 2002-2003, the group's financial statements showed it received more than $670,000 from various drug companies. In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties between CHADD and the drug companies in an interview with Dr William Pelham, director of the Center for Children and Families at State University of New York at Buffalo, a leading ADHD researcher for 30 years, and a former advisory board member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta. Over his career, Dr Pelham has written over 250 research papers on ADHD, and in 2002, he even received a lifetime achievement award from CHADD. However, he has few good words to say about CHADD, regulatory officials, medical professionals, or anybody else involved in selling ADHD drugs to children. "In recent years," Dr Pelham told Alternet, "I have come to believe that the individuals who advocate most strongly in favor of medication - both those from the professional community, including the National Institutes of Mental Health, and those from advocacy groups, including CHADD - have major and undisclosed conflicts of interest with the pharmaceutical companies that deal with ADHD products." "I believe that parents of ADHD children and the public at large should be made aware of this situation," he told Ms Hearn. Representatives of CHADD showed up at the FDA hearings last month and the group will no doubt be out in full force this month ready to go head to head against pharma's number one enemy - the advocacy groups opposed to the mass drugging of children for profit. |
#5
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
Jan Drew wrote: "Mark Probert" [please excuse Mark Probert hissy fits] Another utterly pointless post from Jan, proving only that she can't rebut anything Mark said. snip |
#6
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
Twittering One wrote:
You know, as I have always said, ask the kid. If the kid hates the meds, something is wrong. If the kid feels better on the meds, feels better about his/her abilities, something is right. Are you sure about this? I never took stimulant medicine when I was a kid. When I first took it in my mid 30's, I had a genuine identity crisis. Who is the real me? ... w/o stimulants ... with stimulants It was very, very confusing. I was quite concerned about the issue . ... I continue to revisit the question occasionally. The understanding of an adult is qualitatively different to that of a child. The motivations of adults are different than that of children. It's all to easy to stand here & now and look back as myself as a child considering it from an adult's perspective; from the experience of reality with which I am presently, most familiar. I.E. I am projecting the 'adult' me onto the 'myself' as a child. ... I don't think that it is the same point of view. In short .. I am fooling myself. Frankly, I don't think that any child would choose to take a reality altering drug ( .. on occasion, perhaps to escape fear, or stress ... but these are abberant situations in some ways ) I suspect the kid ... any kid, .. would prefer most of all to be him or her 'self'. Ergo: ... No drug could feel right! Eh? Cordially, RL I went for 24 years before I ever took a an ADD-like med (diet pill) and felt GOOD about my abilities. And then I went another 18 years without any medication options. If I had been offered a choice, I would have taken the meds. But that was another decade. |
#7
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits] There was no hissy fit. I explained why this shill for class-action lawyers has a credibility problem with the so-called "experts". I'll restore the post with my comments intact, as YOU CANNOT handle the TRUTH. Jan Drew wrote: http://www.opednews.com/articles/gen...ts_head_to.htm ADHD Experts Head To Washington - Is the FDA Up To The Task? Excerpts: Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the leading experts on attention deficit disorders at the FDA's Pediatric Advisory Committee's meeting on March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined have authored hundreds of books, papers and reports on attention deficit disorders.* BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study in decades. Breggin's colleague quit that group because he could not stand Breggin's lies. Breggin has been discredited many times in court, when he was allowed to testify. He has not been allowed to testify many times. I previously documented this. Baughman is one of the promotors of the 5 now defunct and dismissed Ritalin lawsuits. He has never published any research regarding AD/HD. Ravenel has never published a research study on AD/HD. Does have some on spanking. Jackson has no published research papers on AD/HD. Stein has no published papers on AD/HD/. Searched PubMed using search string of Last Name, First Initial, AD/HD. BIG Yawn. And all five have one common goal; to put an end to the drugging for profit of the nation's most vulnerable citizens and pharma's most lucrative customer base - innocent children. Yes, Ms. Dingle does have a decidedly anti-medication bias. "These children become for-profit receptacles for psychiatric drugs," he says, "which will, undoubtedly alter their bodies and brains." Studies have determined that ADHD drugs endanger the cardiovascular system and according to Dr Jackson, "the cardiovascular risks of stimulants are hardly new." "As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner documented the cell changes associated with heart muscle enlargement in a chronic consumer of Ritalin." "The connection between stimulants, cardiovascular disability, and death has long been documented in the medical literature," Dr Jackson notes, "but physicians and government regulators have refused to acknowledge the hazards associated with prescriptions." Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs are unnecessary and that their benefits outweigh their risks. "Whether by ignorance or design," Dr Jackson states, "the regulators remain oblivious to the evidence-based limitations of the prescription pad: at least 40% of all children fail to tolerate or respond to stimulant therapy; about twice as many respond at least as well to non-pharmacological interventions; and, as documented in the National Institute of Mental Health's most prestigious study to date (the MTA study), the long term outcomes for medicated children demonstrate diminishing returns over time, persistent suppression of growth (about 1 cm per year), and artificial behavioral improvements which dissipate when treatment is withdrawn." "Not surprisingly," she says, "the world community observes the United States with alarm for the unjustified chemical exploitation of those who are different, but not diseased." "It is hard to imagine a more serious warning flag than growth inhibition," he says, "since it affects the overall growth of the body and all its organs, including the brain." Its a well documented fact that the pharmaceutical industry funnels money to front groups, which in turn fund marketing campaigns and come out to do battle at times like this when drug company profits are threatened and scrutinized. On February 15, 2006, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed front group responsible for pushing ADHD drugs issued a press release criticizing the FDA Advisory Committee's recommendation last month to add black box warnings to the labels of stimulant drugs. The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and charged the organization with being a vehicle for marketing a controlled substance to the public in violation of the international statute known as the Controlled Substances Act of 1971. Ritalin is classified as a Schedule II medication. In order for a product to be classified as a Schedule II drug under the Federal Controlled Substances Act, it must meet three criteria: one, it has to have a high potential for abuse; two, it has to have a currently accepted medical use in treatment in the US; and three, it has to show that abuse may lead to severe psychological or physical dependence. It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin removed from the Schedule II class and moved into a less controlled group to make the drug easier to buy. DEA told Congress that police were reporting that Ritalin was being stolen, sold and traded on playgrounds, as well as snorted, injected, and cut much like any other amphetamine. Although the DEA presented a thorough report, nothing was done to slow the sale of Ritalin to children. And nothing changed as far as CHADD's employment status as a major pusher for Pharma either. For the fiscal year 2002-2003, the group's financial statements showed it received more than $670,000 from various drug companies. In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties between CHADD and the drug companies in an interview with Dr William Pelham, director of the Center for Children and Families at State University of New York at Buffalo, a leading ADHD researcher for 30 years, and a former advisory board member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta. Over his career, Dr Pelham has written over 250 research papers on ADHD, and in 2002, he even received a lifetime achievement award from CHADD. However, he has few good words to say about CHADD, regulatory officials, medical professionals, or anybody else involved in selling ADHD drugs to children. "In recent years," Dr Pelham told Alternet, "I have come to believe that the individuals who advocate most strongly in favor of medication - both those from the professional community, including the National Institutes of Mental Health, and those from advocacy groups, including CHADD - have major and undisclosed conflicts of interest with the pharmaceutical companies that deal with ADHD products." "I believe that parents of ADHD children and the public at large should be made aware of this situation," he told Ms Hearn. Representatives of CHADD showed up at the FDA hearings last month and the group will no doubt be out in full force this month ready to go head to head against pharma's number one enemy - the advocacy groups opposed to the mass drugging of children for profit. |
#8
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
cathyb wrote:
Jan Drew wrote: "Mark Probert" [please excuse Mark Probert hissy fits] Another utterly pointless post from Jan, proving only that she can't rebut anything Mark said. True. Especially about Breggin. |
#9
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
"Mark Probert" wrote: Jan Drew wrote: "Mark Probert" [please excuse Mark Probert hissy fits] There was no hissy fit. I explained why this shill for class-action lawyers has a credibility problem with the so-called "experts". I'll restore the post with my comments intact, as YOU CANNOT handle the TRUTH. Jan Drew wrote: http://www.opednews.com/articles/gen...ts_head_to.htm ADHD Experts Head To Washington - Is the FDA Up To The Task? Excerpts: Heavy-hitters from across the country are heading to Washington this month to debate representatives of the pharmaceutical industry during FDA hearings on the controversy surrounding the over-prescribing of attention deficit drugs to children. The International Center for the Study of Psychiatry and Psychology (ICSPP) will be represented by five of the leading experts on attention deficit disorders at the FDA's Pediatric Advisory Committee's meeting on March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined have authored hundreds of books, papers and reports on attention deficit disorders.* BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study in decades. Breggin's colleague quit that group because he could not stand Breggin's lies. Breggin has been discredited many times in court, when he was allowed to testify. He has not been allowed to testify many times. I previously documented this. Baughman is one of the promotors of the 5 now defunct and dismissed Ritalin lawsuits. He has never published any research regarding AD/HD. Ravenel has never published a research study on AD/HD. Does have some on spanking. Jackson has no published research papers on AD/HD. Stein has no published papers on AD/HD/. Searched PubMed using search string of Last Name, First Initial, AD/HD. BIG Yawn. Mark can NOT post and tell the truth! FACT: Nothing was mentioned about anyone doing a study. FACT: Research Papers weren't mentioned. FACT: Dr Beggin IS a expert. FACT r. David Stein has several books. FACT: Dr. Baughman has authored scientific articles that have appeared in leading national and international medical journals. FACT: The Under Reported Story : ADHD, Stimulants, and the FDA. By Grace E. Jackson MD February 18, 2006 FACT: Dr S DuBose Ravenel http://www.audiblox2000.com/rev00.htm http://pediatrics.aappublications.or...ters/115/1/e97 And all five have one common goal; to put an end to the drugging for profit of the nation's most vulnerable citizens and pharma's most lucrative customer base - innocent children. Yes, Ms. Dingle does have a decidedly anti-medication bias. FACT: You are a name caller, a EXPOSED LIAR , as just proven, A G A I N!!!!!! AND A HARASSER. FACT: (Evelyn Pringle is a columnist for Independent Media TV and an investigative journalist focused on exposing government corruption) "These children become for-profit receptacles for psychiatric drugs," he says, "which will, undoubtedly alter their bodies and brains." Studies have determined that ADHD drugs endanger the cardiovascular system and according to Dr Jackson, "the cardiovascular risks of stimulants are hardly new." "As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner documented the cell changes associated with heart muscle enlargement in a chronic consumer of Ritalin." "The connection between stimulants, cardiovascular disability, and death has long been documented in the medical literature," Dr Jackson notes, "but physicians and government regulators have refused to acknowledge the hazards associated with prescriptions." Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs are unnecessary and that their benefits outweigh their risks. "Whether by ignorance or design," Dr Jackson states, "the regulators remain oblivious to the evidence-based limitations of the prescription pad: at least 40% of all children fail to tolerate or respond to stimulant therapy; about twice as many respond at least as well to non-pharmacological interventions; and, as documented in the National Institute of Mental Health's most prestigious study to date (the MTA study), the long term outcomes for medicated children demonstrate diminishing returns over time, persistent suppression of growth (about 1 cm per year), and artificial behavioral improvements which dissipate when treatment is withdrawn." "Not surprisingly," she says, "the world community observes the United States with alarm for the unjustified chemical exploitation of those who are different, but not diseased." "It is hard to imagine a more serious warning flag than growth inhibition," he says, "since it affects the overall growth of the body and all its organs, including the brain." Its a well documented fact that the pharmaceutical industry funnels money to front groups, which in turn fund marketing campaigns and come out to do battle at times like this when drug company profits are threatened and scrutinized. On February 15, 2006, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed front group responsible for pushing ADHD drugs issued a press release criticizing the FDA Advisory Committee's recommendation last month to add black box warnings to the labels of stimulant drugs. The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and charged the organization with being a vehicle for marketing a controlled substance to the public in violation of the international statute known as the Controlled Substances Act of 1971. Ritalin is classified as a Schedule II medication. In order for a product to be classified as a Schedule II drug under the Federal Controlled Substances Act, it must meet three criteria: one, it has to have a high potential for abuse; two, it has to have a currently accepted medical use in treatment in the US; and three, it has to show that abuse may lead to severe psychological or physical dependence. It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin removed from the Schedule II class and moved into a less controlled group to make the drug easier to buy. DEA told Congress that police were reporting that Ritalin was being stolen, sold and traded on playgrounds, as well as snorted, injected, and cut much like any other amphetamine. Although the DEA presented a thorough report, nothing was done to slow the sale of Ritalin to children. And nothing changed as far as CHADD's employment status as a major pusher for Pharma either. For the fiscal year 2002-2003, the group's financial statements showed it received more than $670,000 from various drug companies. In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties between CHADD and the drug companies in an interview with Dr William Pelham, director of the Center for Children and Families at State University of New York at Buffalo, a leading ADHD researcher for 30 years, and a former advisory board member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta. Over his career, Dr Pelham has written over 250 research papers on ADHD, and in 2002, he even received a lifetime achievement award from CHADD. However, he has few good words to say about CHADD, regulatory officials, medical professionals, or anybody else involved in selling ADHD drugs to children. "In recent years," Dr Pelham told Alternet, "I have come to believe that the individuals who advocate most strongly in favor of medication - both those from the professional community, including the National Institutes of Mental Health, and those from advocacy groups, including CHADD - have major and undisclosed conflicts of interest with the pharmaceutical companies that deal with ADHD products." "I believe that parents of ADHD children and the public at large should be made aware of this situation," he told Ms Hearn. Representatives of CHADD showed up at the FDA hearings last month and the group will no doubt be out in full force this month ready to go head to head against pharma's number one enemy - the advocacy groups opposed to the mass drugging of children for profit. |
#10
|
|||
|
|||
ADHD Experts Head To Washington - Is the FDA Up To The Task?
"Mark Probert" wrote cathyb wrote: Jan Drew wrote: "Mark Probert" [please excuse Mark Probert hissy fits] Another utterly pointless post from Jan, proving only that she can't rebut anything Mark said. True. Especially about Breggin. Bless. |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Is ADHD a Real Disease? | JanD | Kids Health | 46 | March 4th 06 09:42 PM |
BRAVO! Congress Bars Schools From Requiring ADHD Drug Treatment | Ilena Rose | Kids Health | 9 | November 18th 05 11:09 PM |
CNN: FDA panel wants clearer ADHD labels | Ilena Rose | Kids Health | 51 | July 7th 05 09:42 PM |
A Few Simple Truths About ADHD and Stimulant Drugs | Psi | Kids Health | 28 | April 23rd 04 02:40 PM |
Chiro care of baby penises (also: Dr. Poland never sued Dr. Gastaldo) | Todd Gastaldo | Pregnancy | 6 | April 7th 04 04:58 PM |